The cell migration assay showed that HER2 overexpression resulted in a 2.76-fold (P = 0.000) increase in MCF-7 cell migration rate (Fig. 3C), indicating that HER2 overexpression promotes more aggressive biological behaviour in breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.